Review
Published on 01 Apr 2025
Adoptive immune cell therapy for colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557906
- 904 views
Type at least 3 characters
7,540 articles
Case Report
Published on 01 Apr 2025
Successful triple therapy for advanced synchronous multiple primary esophageal carcinoma with metal stenting, photodynamic and comprehensive systemic therapies—shining light on hope: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1580616
- 368 views
Systematic Review
Published on 01 Apr 2025
Toward the benefit and value of immune treatment beyond progression in lung cancer? Insights from a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547978
- 728 views
Case Report
Published on 01 Apr 2025
Immune checkpoint inhibitor-induced anti-Hu antibody-associated gastrointestinal pseudo-obstruction: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1555790
- 553 views
Original Research
Published on 01 Apr 2025
Heterogeneity of γδ T-cell subsets and their clinical correlation in patients with AML
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1552235
- 668 views
Original Research
Published on 01 Apr 2025
Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1534766
- 646 views
Review
Accepted on 31 Mar 2025
From Ex Vivo to In Vitro Models: Towards a Novel Approach to Investigate the Efficacy of Immunotherapies on Exhausted Vγ9Vδ2 T Cells?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1556982
- 109 views
Original Research
Accepted on 31 Mar 2025
CD8+ T Cell Activation in Endometrial Cancer: Prognostic Implications and Potential for
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1542669
Editorial
Accepted on 31 Mar 2025
Interaction of Cell Subtypes in Tumor Microenvironment and Its Implications for Immunotherapy: Summary, Strengths, Weaknesses, and Future
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1600338
- 128 views
Review
Accepted on 31 Mar 2025
Oncolytic Viruses: A Promising Therapy for Malignant Pleural Effusion and Solid Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1570698
- 271 views
Original Research
Accepted on 31 Mar 2025
Immunomodulatory Effects of Intratumoral Cowpea Mosaic Virus and Calreticulin Nanoparticles in Canine Tumors: Early Results
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1566394
- 104 views
Original Research
Accepted on 31 Mar 2025
METTL1-Driven Nucleotide Metabolism Reprograms the Immune Microenvironment in Hepatocellular Carcinoma: A Multi-Omics Approach for Prognostic Biomarker Discovery
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1582203
Original Research
Accepted on 31 Mar 2025
Running head: The miR-941/FOXN4/TGF-β feedback loop promotes LUAD
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561081
Original Research
Accepted on 31 Mar 2025
Advancing Personalized, Predictive, and Preventive Medicine (PPPM/3PM) in Bladder Cancer: A Multi-Omics and Machine Learning Approach for Novel Prognostic Modeling, Immune Profiling, and Therapeutic Target Discovery
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1572034
- 102 views
Review
Accepted on 31 Mar 2025
Mechanistic Insights into Resistance Mechanisms to T Cell Engagers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1583044
Original Research
Accepted on 31 Mar 2025
Comprehensive Analysis of Plasma Cell Heterogeneity and Immune Interactions in multiple Myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1549742